Article info

Original research
Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study

Authors

  • Chiamaka Esther Amaefule BARC (Barts Research Centre for Women’s Health), Institute of Population Health Sciences, Queen Mary University of London Barts and The London School of Medicine and Dentistry, London, UK PubMed articlesGoogle scholar articles
  • Zoe Drymoussi BARC (Barts Research Centre for Women’s Health), Institute of Population Health Sciences, Queen Mary University of London Barts and The London School of Medicine and Dentistry, London, UK PubMed articlesGoogle scholar articles
  • Francisco Jose Gonzalez Carreras BARC (Barts Research Centre for Women’s Health), Institute of Population Health Sciences, Queen Mary University of London Barts and The London School of Medicine and Dentistry, London, UK PubMed articlesGoogle scholar articles
  • Maria del Carmen Pardo Llorente Department of Statistics and Operational Research, Complutense University of Madrid, Madrid, Spain PubMed articlesGoogle scholar articles
  • Doris Lanz BARC (Barts Research Centre for Women’s Health), Institute of Population Health Sciences, Queen Mary University of London Barts and The London School of Medicine and Dentistry, London, UK PubMed articlesGoogle scholar articles
  • Julie Dodds BARC (Barts Research Centre for Women’s Health), Institute of Population Health Sciences, Queen Mary University of London Barts and The London School of Medicine and Dentistry, London, UK PubMed articlesGoogle scholar articles
  • Lorna Sweeney Institute for Health and Human Development, University of East London, London, UK PubMed articlesGoogle scholar articles
  • Elena Pizzo NIHR ARC (Applied Health Collaborations) for North Thames London, Department of Applied Health Research, University College London, London, UK PubMed articlesGoogle scholar articles
  • Amy Thomas BARC (Barts Research Centre for Women’s Health), Institute of Population Health Sciences, Queen Mary University of London Barts and The London School of Medicine and Dentistry, London, UKWomen’s and Children’s Health, Barts Health NHS Trust, The Royal London Hospital, London, UK PubMed articlesGoogle scholar articles
  • James Heighway BARC (Barts Research Centre for Women’s Health), Institute of Population Health Sciences, Queen Mary University of London Barts and The London School of Medicine and Dentistry, London, UK PubMed articlesGoogle scholar articles
  • Jahnavi Daru BARC (Barts Research Centre for Women’s Health), Institute of Population Health Sciences, Queen Mary University of London Barts and The London School of Medicine and Dentistry, London, UK PubMed articlesGoogle scholar articles
  • Soha Sobhy BARC (Barts Research Centre for Women’s Health), Institute of Population Health Sciences, Queen Mary University of London Barts and The London School of Medicine and Dentistry, London, UKWomen’s and Children’s Health, Barts Health NHS Trust, The Royal London Hospital, London, UK PubMed articlesGoogle scholar articles
  • Lucilla Poston Department of Women and Children’s Health, Faculty of Life Sciences and Medicine, King's College London, London, UK PubMed articlesGoogle scholar articles
  • Asma Khalil Department of Obstetrics and Gynaecology, St George's Hospital, London, UKVascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK PubMed articlesGoogle scholar articles
  • Jenny Myers Maternal and Fetal Health Research Centre, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Angela Harden Institute for Health and Human Development, University of East London, London, UK PubMed articlesGoogle scholar articles
  • Graham Hitman Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, London, UK PubMed articlesGoogle scholar articles
  • Khalid Saeed Khan Department of Preventive Medicine and Public Health, Universidad de Granada, Granada, Spain PubMed articlesGoogle scholar articles
  • Javier Zamora Clinical Biostatistics Unit and CIBER Epidemiology and Public Health, IRYCIS, Madrid, SpainWHO Collaborating Centre for Global Women’s Health, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK PubMed articlesGoogle scholar articles
  • Teresa Pérez BARC (Barts Research Centre for Women’s Health), Institute of Population Health Sciences, Queen Mary University of London Barts and The London School of Medicine and Dentistry, London, UKDepartment of Statistics and Data Science, Complutense University of Madrid, Madrid, Spain PubMed articlesGoogle scholar articles
  • Mohammed S B Huda Barts Health NHS Trust, The Royal London Hospital, Department of Diabetes and Metabolism, London, UK PubMed articlesGoogle scholar articles
  • Shakila Thangaratinam WHO Collaborating Centre for Global Women’s Health, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UKBirmingham Women's and Children's NHS Foundation Trust, Birmingham, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Shakila Thangaratinam; s.thangaratinam.1{at}bham.ac.uk
View Full Text

Citation

Amaefule CE, Drymoussi Z, Gonzalez Carreras FJ, et al
Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study

Publication history

  • Received February 9, 2021
  • Accepted February 8, 2022
  • First published March 11, 2022.
Online issue publication 
December 08, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.